Standout Papers

Is a p53-Regulated Inhibitor of G2/M Progression 1992 2026 2003 2014 1.2k
  1. Is a p53-Regulated Inhibitor of G2/M Progression (1997)
    Heiko Hermeking, Christoph Lengauer et al. Molecular Cell
  2. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 (1993)
    Jonathan D. Oliner, Jennifer A. Pietenpol et al. Nature
  3. Oncogenic forms of p53 inhibit p53-regulated gene expression (1992)
    S E Kern, JA Pietenpol et al. Science
  4. Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code (2003)
    Sam Thiagalingam, Kuang‐Hung Cheng et al. Annals of the New York Academy of Sciences

Immediate Impact

5 by Nobel laureates 50 from Science/Nature 131 standout
Sub-graph 1 of 11

Citing Papers

Emerging Biological Principles of Metastasis
2017 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
5 intermediate papers

Works of Sam Thiagalingam being referenced

Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers.
1999
Oncogenic forms of p53 inhibit p53-regulated gene expression
1992 StandoutScience
and 3 more

Author Peers

Author Last Decade Papers Cites
Sam Thiagalingam 6684 1459 4228 72 8.8k
Steven R. Grossman 4777 1122 2873 100 7.7k
Teresa L. Yang‐Feng 7953 2138 3291 104 13.5k
Zao-zhong Su 3415 1256 2657 69 6.6k
Mark J. McArthur 4247 739 3606 45 6.9k
H. Earl Ruley 6267 2437 4457 74 10.0k
Charles A. Montgomery 5803 1893 4319 53 10.2k
Susan L. Naylor 6878 2228 1238 148 10.6k
Suzanne J. Baker 9777 2055 7242 119 16.9k
Bernhard Radlwimmer 4754 1126 1901 96 8.5k
Sarah J. Parsons 6238 803 2978 115 9.6k

All Works

Loading papers...

Rankless by CCL
2026